X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4874) 4874
Publication (600) 600
Book Review (56) 56
Book Chapter (20) 20
Conference Proceeding (8) 8
Magazine Article (4) 4
Dissertation (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
progression-free survival (3926) 3926
humans (3406) 3406
index medicus (3006) 3006
oncology (2650) 2650
female (2188) 2188
middle aged (1883) 1883
male (1848) 1848
aged (1651) 1651
adult (1391) 1391
cancer (1320) 1320
chemotherapy (1312) 1312
prognosis (1130) 1130
treatment outcome (1109) 1109
disease-free survival (1070) 1070
survival (1006) 1006
overall survival (847) 847
care and treatment (761) 761
retrospective studies (761) 761
antineoplastic combined chemotherapy protocols - therapeutic use (748) 748
aged, 80 and over (684) 684
hematology (672) 672
metastasis (642) 642
antineoplastic agents - therapeutic use (571) 571
therapy (539) 539
analysis (538) 538
research (486) 486
patients (478) 478
tumors (469) 469
neoplasm staging (459) 459
survival analysis (448) 448
surgery (434) 434
disease progression (429) 429
kaplan-meier estimate (425) 425
survival rate (421) 421
clinical trials (418) 418
medicine & public health (403) 403
progression-free (397) 397
development and progression (373) 373
patient outcomes (367) 367
hematology, oncology and palliative medicine (365) 365
young adult (361) 361
rituximab (342) 342
medical prognosis (332) 332
carcinoma (320) 320
time factors (317) 317
radiotherapy (314) 314
follow-up studies (302) 302
risk factors (297) 297
progression free survival (294) 294
drug therapy (291) 291
bevacizumab (288) 288
trial (288) 288
health aspects (281) 281
adolescent (280) 280
phase-ii trial (278) 278
pharmacology & pharmacy (275) 275
breast cancer (274) 274
open-label (274) 274
neoplasm metastasis (271) 271
recurrence (270) 270
cancer therapies (267) 267
transplantation (267) 267
non-hodgkins-lymphoma (265) 265
proportional hazards models (265) 265
clinical neurology (263) 263
combined modality therapy (259) 259
phase-iii trial (254) 254
article (241) 241
medical research (241) 241
biomarkers (239) 239
abridged index medicus (236) 236
ovarian cancer (235) 235
randomized controlled trials as topic (234) 234
expression (233) 233
phase-iii (233) 233
antineoplastic combined chemotherapy protocols - adverse effects (231) 231
phase-ii (231) 231
mutation (227) 227
diagnosis (222) 222
immunotherapy (217) 217
metastases (215) 215
multivariate analysis (207) 207
lymphomas (205) 205
studies (205) 205
colorectal cancer (201) 201
prospective studies (201) 201
cisplatin (200) 200
glioblastoma (200) 200
lung cancer (198) 198
efficacy (196) 196
radiology, nuclear medicine & medical imaging (196) 196
neoplasms. tumors. oncology. including cancer and carcinogens (193) 193
usage (189) 189
lung neoplasms - drug therapy (187) 187
antineoplastic agents - administration & dosage (186) 186
randomized-trial (183) 183
toxicity (182) 182
antineoplastic agents (178) 178
clinical-trials (177) 177
radiation-therapy (177) 177
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4683) 4683
Chinese (58) 58
German (41) 41
French (27) 27
Spanish (26) 26
Korean (18) 18
Russian (15) 15
Polish (9) 9
Czech (5) 5
Hungarian (5) 5
Japanese (5) 5
Turkish (3) 3
Portuguese (2) 2
Dutch (1) 1
Esperanto (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 08/2015, Volume 175, Issue 8, pp. 1389 - 1398
Journal Article
Statistics in Medicine, ISSN 0277-6715, 02/2019, Volume 38, Issue 5, pp. 703 - 719
This paper considers methods for estimating the association between progression‐free and overall survival in oncology trials. Copula‐based, nonparametric, and... 
overall survival | Kendall's τ | copula | progression‐free survival | inverse probability of censoring weights | multistate model | progression-free survival
Journal Article
Cancer, ISSN 0008-543X, 03/2011, Volume 117, Issue 6, pp. 1262 - 1271
BACKGROUND: The authors investigated the putative surrogate endpoints of best response, complete response (CR), confirmed response, and progression‐free... 
extensive stage small‐cell lung cancer | pooled analysis | tumor response | surrogate endpoints | progression‐free survival | extensive stage small-cell lung cancer | progression-free survival
Journal Article
Journal Article